Details for New Drug Application (NDA): 090494
✉ Email this page to a colleague
The generic ingredient in CLOPIDOGREL BISULFATE is clopidogrel bisulfate. There are fifty-four drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the clopidogrel bisulfate profile page.
Summary for 090494
| Tradename: | CLOPIDOGREL BISULFATE |
| Applicant: | Sun Pharm |
| Ingredient: | clopidogrel bisulfate |
| Patents: | 0 |
Pharmacology for NDA: 090494
| Mechanism of Action | Cytochrome P450 2C8 Inhibitors P2Y12 Receptor Antagonists |
| Physiological Effect | Decreased Platelet Aggregation |
Suppliers and Packaging for NDA: 090494
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 090494 | ANDA | Sun Pharmaceutical Industries, Inc. | 47335-894 | 47335-894-13 | 500 TABLET, FILM COATED in 1 BOTTLE (47335-894-13) |
| CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 090494 | ANDA | Sun Pharmaceutical Industries, Inc. | 47335-894 | 47335-894-18 | 1000 TABLET, FILM COATED in 1 BOTTLE (47335-894-18) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 75MG BASE | ||||
| Approval Date: | May 17, 2012 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
